No Data
No Data
DexCom, Inc. (DXCM): A Bull Case Theory
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $98
What's Driving the Market Sentiment Around DexCom?
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Vera Therapeutics (VERA) and Dexcom (DXCM)
ŌURA Rolls Out Glucose App Linked With Dexcom's CGM Stelo
New Analyst Forecast: $DXCM Given 'Overweight' Rating